RESEARCH ALERT-Roth Capital raises Synta Pharmaceuticals price target

Oct 1 (Reuters) - Synta Pharmaceuticals Corp :

* Roth Capital raises Synta Pharmaceuticals Corp price target to $16

from $10; rating buy

For a summary of rating and price target changes on U.S. companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .1568

For a summary of rating and price target changes on Canadian companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .4899

((Bangalore Equities Newsdesk [phone]; within U.S. [phone]))

((Bangalore Equities Newsdesk [phone]; within U.S. [phone]))